Inflammatix Completes Technical Development for TriVerity™ Acute Infection and Sepsis Test System

Company Reaches Important Product Development Milestone with its Myrna™ Instrument and TriVerity Cartridge SUNNYVALE, Calif., Nov. 15, 2023 /PRNewswire/ — Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the company has completed technical development…

Click here to view original post